Jason Pitofsky's most recent trade in Regeneron Pharmaceuticals, Inc. was a trade of 1,000 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2026 | 1,000 | 905 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 492.00 per share. | 09 Feb 2026 | 1,000 | 6,308 (0%) | 0% | 492 | 492,000 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 778.35 per share. | 09 Feb 2026 | 563 | 4,813 (0%) | 0% | 778.3 | 438,211 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 776.43 per share. | 09 Feb 2026 | 521 | 5,767 (0%) | 0% | 776.4 | 404,520 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 777.51 per share. | 09 Feb 2026 | 391 | 5,376 (0%) | 0% | 777.5 | 304,006 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 779.56 per share. | 09 Feb 2026 | 205 | 4,608 (0%) | 0% | 779.6 | 159,810 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 783.23 per share. | 09 Feb 2026 | 144 | 4,326 (0%) | 0% | 783.2 | 112,785 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 780.07 per share. | 09 Feb 2026 | 75 | 4,533 (0%) | 0% | 780.1 | 58,505 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 785.72 per share. | 09 Feb 2026 | 53 | 4,272 (0%) | 0% | 785.7 | 41,643 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 782.68 per share. | 09 Feb 2026 | 37 | 4,470 (0%) | 0% | 782.7 | 28,959 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 781.38 per share. | 09 Feb 2026 | 26 | 4,507 (0%) | 0% | 781.4 | 20,316 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 775.95 per share. | 09 Feb 2026 | 20 | 6,288 (0%) | 0% | 776.0 | 15,519 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | SVP Controller | Sale of securities on an exchange or to another person at price $ 785.00 per share. | 09 Feb 2026 | 1 | 4,325 (0%) | 0% | 785 | 785 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2025 | 2,261 | 2,261 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2025 | 2,064 | 6,297 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 712.94 per share. | 05 Dec 2025 | 989 | 5,308 (0%) | 0% | 712.9 | 705,098 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Sale of securities on an exchange or to another person at price $ 651.43 per share. | 07 Nov 2025 | 431 | 4,233 (0%) | 0% | 651.4 | 280,766 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.81 per share. | 16 Dec 2024 | 298 | 4,664 (0%) | 0% | 730.8 | 217,781 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 3,236 | 3,236 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 907 | 5,111 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 787.00 per share. | 06 Dec 2024 | 149 | 4,962 (0%) | 0% | 787 | 117,263 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2024 | 90 | 179 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2024 | 89 | 89 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2024 | 487 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Sale of securities on an exchange or to another person at price $ 1070.00 per share. | 07 Aug 2024 | 487 | 4,204 (0%) | 0% | 1070 | 521,090 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 07 Aug 2024 | 487 | 4,691 (0%) | 0% | 372.5 | 181,388 | Common Stock |